P-016 Successful Flow Diversion of Cerebral Aneurysms in Plavix Hyporesponders (PRU >= 200): An Argument for Antiplatelet Monotherapy?

ConclusionsHyporesponse to Plavix (PRU ≥ 200) is not a contraindication to aneurysm treatment with the PED in patients on a standard dual antiplatelet regimen of Aspirin 325 mg and Plavix 75 mg daily. These data suggest a diminutive role of Plavix in preventing thrombotic complications during these procedures.DisclosuresG. Colby: 1; C; Stryker, Medtronic. 2; C; Microvention. L. Lin: 1; C; Stryker. D. Lubelski: None. M. Bender: None. R. Xu: None. B. Jiang: None. J. Huang: None. R. Tamargo: None. A. Coon: 1; C; Sequent. 2; C; Stryker, Medtronic, Microvention, Sequent.

Source: Journal of NeuroInterventional Surgery - July 28, 2016 Category: Neurosurgery Authors: Colby, G., Lin, L., Lubelski, D., Bender, M., Xu, R., Jiang, B., Huang, J., Tamargo, R., Coon, A. Tags: Oral poster abstracts Source Type: research